Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	9.68	50.53	46.06
Graham Fair Price	-25.04	161149.15	214980.19
PEG	25.04	-0.62	-0.82
Price/Book	-4.77	1.61	1.69
Price/Cash Flow	1.69	-25.93	-26.37
Prices/Earnings	76.62	27.79	15.73
Price/Sales	5.44	5.92	5.61
Price/FCF	1.69	-25.93	-26.37
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.78	0.17	0.17
Operating Margin	-23.25	0.04	0.06
ROA	-47.15	< 0.005	0.01
ROE	0.03	0.01	-46.08
ROIC	< 0.005	< 0.005	7.30
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.10	0.05	95.11
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.37	-0.29	21.21
EPS QOQ	-0.19	-0.45	-135.62
FCF QOQ	-0.64	0.01	-98.26
Revenue QOQ	-0.06	-0.08	-20.98
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	64.45	70.73	9.74
Days Sales Outstanding (DSO)	55.38	63.67	14.97
Inventory Turnover	1.40	1.27	-8.88
Debt/Capitalization	0.24	0.25	5.72
Quick Ratio	0.65	0.64	-0.11
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	276815.37	282583.17	2.08
Cash	31022.99	40521.19	30.62
Capex	-24072.22	-12160.86	49.48
Free Cash Flow	-17706.55	-17510.15	1.11
Revenue	83214.38	76726.35	-7.80
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.08	1.02	-5.27
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.55	5.90	6.42
Naive Interpretation	Member

06 - Financial Health · Bad

Rating